Quarterly report pursuant to Section 13 or 15(d)

The following table summarizes the components of the purchase consideration (in thousands): (Details)

v3.24.2.u1
The following table summarizes the components of the purchase consideration (in thousands): (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Business Acquisition [Line Items]      
Closing cash consideration   $ 22,174
Upsher-Smith Laboratories, LLC [Member]      
Business Acquisition [Line Items]      
Closing cash consideration $ 22,174    
Inventory adjustment payment liability 1,348    
Deferred payment liability 3,000    
Purchase price to be allocated $ 26,522